4/17 Webinar: How to take back control of your #ITHelpdesk from #Slack DMs. Cohere, Xilio Therapeutics, Foqal share experience. Register here: https://hubs.ly/Q02pyRpN0
Foqal’s Post
More Relevant Posts
-
Check this out! As a scientist, patent attorney and entrepreneur, I believe that innovation is the genesis of therapeutics that changes patients lives. Get informed and support strong patent rights to protect these innovations and the businesses that they help build!
very proud to announce that Dr. Jennifer Cheng, founder and CEO of PTM Therapeutics, has a published an op-ed article in The Mercury News concerning the TRIPS Waiver extension. you can read it here: https://lnkd.in/gtjGi-NJ
To view or add a comment, sign in
-
#Slack DMs can make it hard to track requests and measure workload impact of your #ITHelpdesk. Hear how Cohere, Xilio Therapeutics and Foqal took back control 4/17 webinar https://hubs.li/Q02pyTc90
To view or add a comment, sign in
-
Discover how VLE Therapeutics sets the gold standard in lentiviral vector (LV) production. Our streamlined methods pave the way for next-generation therapeutics, delivering superior quality and efficiency. Learn more 👉 https://ow.ly/a5IJ50SeEr7
To view or add a comment, sign in
-
Discover how VLE Therapeutics sets the gold standard in lentiviral vector (LV) production. Our streamlined methods pave the way for next-generation therapeutics, delivering superior quality and efficiency. Learn more 👉 https://ow.ly/a5IJ50SeEr7
To view or add a comment, sign in
-
#Slack DMs can make it hard to track requests and measure workload impact of your #ITHelpdesk. Hear how Cohere, Xilio Therapeutics and Foqal took back control in 4/17 webinar https://hubs.ly/Q02pyQ0V0
To view or add a comment, sign in
-
Do you want an update on what's been happening at Argenica Therapeutics? This morning, we released our most recent Investor Presentation, providing an update on our Phase 2 Clinical Trial. Read the full presentation here➡️ https://bit.ly/4f4NZ70 #clinicaltrial #investorupdate #AGN #ASX #stroke #strokeawareness
To view or add a comment, sign in
-
Undifferentiated Pleomorphic Sarcoma Therapeutics Market Size, Share Analysis, Value and Report 2023-2030 https://lnkd.in/eczhiwFa #marketanalysis #marketresearch #marketresearchreports #businessintelligence
To view or add a comment, sign in
-
If you missed the December 1st webinar from ReCode Therapeutics, the recording is now available at the link below! Watch today to learn about the clinical trials process. https://lnkd.in/gnZ5fKY6
To view or add a comment, sign in
-
Last week, Argenica Therapeutics lodged our Appendix 4C Quarterly Cashflow Report for the 12-month period ended 30 June 2024. One key highlight from the report was the progress made in our Phase 2 Clinical Trial. Here is an overview of the highlight Access the full report here ➡️ https://bit.ly/4ftygiq #ASX #AGN #investorupdate #stroke #clinicaltrial
To view or add a comment, sign in
-
Join our webinar with Cuong Do, founder and Chairman of M6P Therapeutics, to hear how their breakthrough technology is driving the development of the next generation of enzyme replacement therapies for a wide range of conditions. July 23 at 11 AM ET https://hubs.la/Q02GYPpY0
To view or add a comment, sign in
375 followers